Texas Yale Capital Corp’s Lombard Medical, Inc. EVAR Stock Holding History

Texas Yale Capital Corp’s Portfolio EVAR Stock Details EVAR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-34,383	Closed	-$32K	–	457
2016 Q3	$32K	Buy	34,383 +5,321	+18%	+$5.64K	﹤0.01%	441
2016 Q2	$32K	Hold	29,062	–	–	﹤0.01%	446
2016 Q1	$31K	Buy	+29,062	New	+$25.9K	﹤0.01%	444

Other funds holding EVAR

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

SHI

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Texas Yale Capital Corp's EVAR Position: Q4 2016 in Review

Texas Yale Capital Corp sold out of Lombard Medical, Inc. (EVAR) in Q4 2016, closing a stake of 34,383 shares — an estimated $32K sold.

Texas Yale Capital Corp first reported a position in EVAR in Q1 2016 and held it in 3 quarters. The position peaked at $32K in Q3 2016. 9 funds tracked by Wall St. Rank hold EVAR as of Q4 2016.

Texas Yale Capital Corp reported no remaining Lombard Medical, Inc. position as of Q4 2016 after selling out during the quarter.
Texas Yale Capital Corp sold 34,383 Lombard Medical, Inc. shares in Q4 2016, an estimated $32K.
Texas Yale Capital Corp first reported a position in Lombard Medical, Inc. in Q1 2016 and held it in 3 quarters.
Texas Yale Capital Corp's Lombard Medical, Inc. position peaked at $32K in Q3 2016.
9 funds tracked by Wall St. Rank held Lombard Medical, Inc. as of Q4 2016.

Based on Texas Yale Capital Corp's 13F filing for Q4 2016, filed 13 Feb 2017.